RxDoctor Payments Data

Amy Muchowicz

Nurse Practitioner · Omaha, NENPI 1245518661

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $75,328 of the $78,467 with a category attached, or 96.0%. Organon accounts for 90.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $34,540 and has fallen 99.5% since, to $186 in 2025. Among nurse practitioner clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,467in general payments, 2019–2025

Across 228 payments — averaging $344.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$71K
  • Merck$5K
  • AbbVie$1K
  • Galderma Laboratories, L.p.$518

What the payments were for

  • Speaking & faculty fees$75,32896%
  • Travel & lodging$3820%
  • Food & beverage$2,7403%
  • Education$170%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon155$71,347
Merck9$5,336
AbbVie(2 entities)49$1,265
Galderma Laboratories, L.p.15$518

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,467 in reported general payments places this provider in the 95th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska →

Other nurse practitioner in Omaha

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →